Navigation Links
Teva's Forum Draws Key Pennsylvania Healthcare Leaders
Date:7/30/2009

State Influentials Gather to Discuss the Rising Cost of Medicine for Consumers

PHILADELPHIA, July 30 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today hosted the last in a series of roundtable discussions focused on increasing access to healthcare and affordable medicines in the United States.

The event was held as a part of the company's Year of Affordable Healthcare Campaign (www.yearofaffordablehealth.com), which marks the 25th anniversary of the passing of the Hatch-Waxman Act, a bill which created the modern day pharmaceutical drug industry.

The event featured panelists from around the Philadelphia area, all of whom have distinguished themselves by helping to bring affordable healthcare solutions to the people of Pennsylvania. They included:

  • Thomas Snedden, Director, Pennsylvania Pharmaceutical Assistance Contract for the Elderly
  • Pat Halpin-Murphy, President and Founder, Pennsylvania Breast Cancer Coalition
  • Dr. Janet Young, Medical Director, Greater Philadelphia Health Action, Inc.
  • Donna Duncan, Executive Director, Philadelphia's Linda Creed Breast Cancer Foundation

The panel was moderated by Pam Gilbert, partner at Cuneo Gilbert & LaDuca and former executive director of the Consumer Product Safety Commission.

"We are now at a crucial point in this debate," said Debra Barrett, Senior Vice President of Government Affairs for Teva Pharmaceuticals USA. "Healthcare costs continue to rise and consumers in some cases are struggling to access care. We need to ensure that affordable medicine options like biogenerics are available, so that Pennsylvania citizens don't have to worry about being able to afford their prescriptions."

The spirited discussion centered around the need for healthcare reform, the steadily increasing costs of medicines and treatments and potential solutions for these rising costs -- including the development of a pathway for generic biologic medicines.

About Teva USA

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
2. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
3. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
4. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
5. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
6. Sponsor of Presidential Health Care Forum Has a $4 Billion Conflict of Interest: Kucinich
7. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
8. National Quality Forum Announces New Member Councils Leadership
9. American Society of Transplantations Past President Testifies Before Congress at Forum on Organ Donation
10. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
11. SGX Pharmaceuticals to Present at the BIO InvestorForum 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... September 26, 2017 , ... Atmosera , a ... Management as a Service (RMaaS) to automate the deployment of websites and ... companies, e-tailers, and web development agencies who want to improve time-to-revenue with a ...
(Date:9/26/2017)... ... , ... As the holiday season nears, best deals online website, ... to find tips and stories for products and services savings. With a lot of ... deals. The deals are organized by categories so can easily find what you’re looking ...
(Date:9/26/2017)... Falls Church, VA (PRWEB) , ... September 26, 2017 , ... ... FDAnews and Cerulean Associates LLC **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity ... its investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy ...
(Date:9/26/2017)... ... September 26, 2017 , ... Autism Learning ... Northern Colorado. Aspire Autism, A Division of Autism Learning Partners, will be the ... Aspire provides center based Autism services in Broomfield and will continue to operate ...
(Date:9/26/2017)... ... September 26, 2017 , ... The Organizing Committee ... tactical plans for Pittcon 2018. As of July 1, Adrian C. Michael, Ph.D. ... named vice president, Charles Gardner, (ChemImage Corporation) and selected chairs. , ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BioLife Solutions , Inc. (NASDAQ: BLFS ), the ... and tissue hypothermic storage and cryopreservation freeze ... and CEO, will be presenting at two investment conferences in ... th Annual Global Investment Conference on Tuesday, September 12th, ... conference is being held at the New York Palace Hotel ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: